Ziglim-M1 Tablet PR: A Dual-Action Approach to Diabetes Management

Ziglim-M1 Tablet PR, a combination tablet of Glimepiride (1mg) and Metformin (500mg), provides an effective approach for managing type 2 diabetes. These medications work synergistically to regulate blood sugar levels by controlling the production of glucose in the liver and improving insulin sensitivity.

Glimepiride directly stimulates insulin secretion from the pancreas, while Metformin helps reduce hepatic glucose production, further lowering blood glucose levels. This combination offers a comprehensive approach for effective management of hyperglycemia.

Ziglim-M1 Tablet PR is available in a convenient, pre-sorted package for easy administration. It's designed for long-term use under medical supervision to help individuals achieve and maintain optimal glycemic control, ultimately reducing the risk of complications associated with diabetes.

Please note: This medication should only be used as prescribed by your doctor. Seek professional guidance before starting or changing any medications.